The rat sarcoma/mitogen-activated protein kinase (RAS/MAPK) pathway culminates in altered expression of genes related to proliferation, apoptosis and differentiation translating amplified signalling through HER2 into increased cancer progression [14]. Here, ERBB2 is linked to cancer.